Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2008 2
2009 2
2010 3
2011 1
2012 1
2013 3
2015 1
2016 2
2017 3
2018 2
2019 1
2020 2
2021 5
2022 4
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
Gasdermin D inhibition prevents multiple organ dysfunction during sepsis by blocking NET formation.
Silva CMS, Wanderley CWS, Veras FP, Sonego F, Nascimento DC, Gonçalves AV, Martins TV, Cólon DF, Borges VF, Brauer VS, Damasceno LEA, Silva KP, Toller-Kawahisa JE, Batah SS, Souza ALJ, Monteiro VS, Oliveira AER, Donate PB, Zoppi D, Borges MC, Almeida F, Nakaya HI, Fabro AT, Cunha TM, Alves-Filho JC, Zamboni DS, Cunha FQ. Silva CMS, et al. Among authors: borges mc. Blood. 2021 Dec 23;138(25):2702-2713. doi: 10.1182/blood.2021011525. Blood. 2021. PMID: 34407544 Free PMC article.
The authors reply.
Campos DR, Gosselink R, Borges MC. Campos DR, et al. Among authors: borges mc. Crit Care Med. 2022 Sep 1;50(9):e737-e738. doi: 10.1097/CCM.0000000000005611. Epub 2022 Aug 15. Crit Care Med. 2022. PMID: 35984073 No abstract available.
Sepsis expands a CD39+ plasmablast population that promotes immunosuppression via adenosine-mediated inhibition of macrophage antimicrobial activity.
Nascimento DC, Viacava PR, Ferreira RG, Damaceno MA, Piñeros AR, Melo PH, Donate PB, Toller-Kawahisa JE, Zoppi D, Veras FP, Peres RS, Menezes-Silva L, Caetité D, Oliveira AER, Castro ÍMS, Kauffenstein G, Nakaya HI, Borges MC, Zamboni DS, Fonseca DM, Paschoal JAR, Cunha TM, Quesniaux V, Linden J, Cunha FQ, Ryffel B, Alves-Filho JC. Nascimento DC, et al. Immunity. 2021 Sep 14;54(9):2024-2041.e8. doi: 10.1016/j.immuni.2021.08.005. Epub 2021 Sep 1. Immunity. 2021. PMID: 34473957 Free article.
Asthma self-management model: randomized controlled trial.
Olivera CM, Vianna EO, Bonizio RC, de Menezes MB, Ferraz E, Cetlin AA, Valdevite LM, Almeida GA, Araujo AS, Simoneti CS, de Freitas A, Lizzi EA, Borges MC, de Freitas O. Olivera CM, et al. Among authors: borges mc. Health Educ Res. 2016 Oct;31(5):639-52. doi: 10.1093/her/cyw035. Epub 2016 Jul 29. Health Educ Res. 2016. PMID: 27473571 Clinical Trial.
Chloroquine use improves dengue-related symptoms.
Borges MC, Castro LA, Fonseca BA. Borges MC, et al. Mem Inst Oswaldo Cruz. 2013 Aug;108(5):596-9. doi: 10.1590/s0074-02762013000500010. Mem Inst Oswaldo Cruz. 2013. PMID: 23903975 Free PMC article. Clinical Trial.
The impact of an enhanced health surveillance system for COVID-19 management in Serrana, Brazil.
Ferreira NN, Garibaldi PMM, Moraes GR, Moura JC, Klein TM, Machado LE, Scofoni LFB, Haddad SK, Calado RT, Covas DT, Fonseca BAL, Palacios R, Conde MTRP, Borges MC. Ferreira NN, et al. Among authors: borges mc. Public Health Pract (Oxf). 2022 Dec;4:100301. doi: 10.1016/j.puhip.2022.100301. Epub 2022 Aug 5. Public Health Pract (Oxf). 2022. PMID: 35946045 Free PMC article.
Chronic Toxoplasma gondii Infection Exacerbates Secondary Polymicrobial Sepsis.
Souza MC, Fonseca DM, Kanashiro A, Benevides L, Medina TS, Dias MS, Andrade WA, Bonfá G, Silva MAB, Gozzi A, Borges MC, Gazzinelli RT, Alves-Filho JC, Cunha FQ, Silva JS. Souza MC, et al. Among authors: borges mc. Front Cell Infect Microbiol. 2017 Apr 7;7:116. doi: 10.3389/fcimb.2017.00116. eCollection 2017. Front Cell Infect Microbiol. 2017. PMID: 28439500 Free PMC article.
Beneficial effects of colchicine for moderate to severe COVID-19: a randomised, double-blinded, placebo-controlled clinical trial.
Lopes MI, Bonjorno LP, Giannini MC, Amaral NB, Menezes PI, Dib SM, Gigante SL, Benatti MN, Rezek UC, Emrich-Filho LL, Sousa BAA, Almeida SCL, Luppino Assad R, Veras FP, Schneider A, Rodrigues TS, Leiria LOS, Cunha LD, Alves-Filho JC, Cunha TM, Arruda E, Miranda CH, Pazin-Filho A, Auxiliadora-Martins M, Borges MC, Fonseca BAL, Bollela VR, Del-Ben CM, Cunha FQ, Zamboni DS, Santana RC, Vilar FC, Louzada-Junior P, Oliveira RDR. Lopes MI, et al. Among authors: borges mc. RMD Open. 2021 Feb;7(1):e001455. doi: 10.1136/rmdopen-2020-001455. RMD Open. 2021. PMID: 33542047 Free PMC article. Clinical Trial.
33 results